A Recombinant Shigella flexneri Strain Expressing ETEC Heat-Labile Enterotoxin B Subunit Shows Promise for Vaccine...

Area of Science:

• Microbiology and Immunology
• Vaccine Development
• Molecular Biology

Background:

• Diarrheal diseases caused by Shigella and enterotoxigenic Escherichia coli (ETEC) pose significant global health challenges, particularly in regions with high child mortality.
• Limited vaccine options and increasing antibiotic resistance necessitate innovative approaches for controlling these infections.

Purpose of the Study:

• To develop a stable, non-replicating subunit vaccine candidate offering cross-protection against Shigella and ETEC.
• To engineer a recombinant Shigella flexneri strain to express the heat-labile enterotoxin B (LTB) subunit of ETEC.

Main Methods:

• Genetic engineering of Shigella flexneri to stably incorporate the ETEC eltb gene.
• Production and isolation of outer membrane vesicles (OMVs) from the recombinant strain.
• Validation of LTB expression using GM1-capture ELISA and proteomic analysis of OMVs.

Main Results:

• Successful and stable expression of ETEC's LTB subunit within Shigella OMVs.
• Proteomic analysis confirmed the presence of LTB alongside key Shigella outer membrane proteins and virulence factors.
• LTB expression levels in the engineered OMVs were comparable to those produced by ETEC.

Conclusions:

• Engineered Shigella OMVs carrying ETEC's LTB represent a promising subunit vaccine candidate.
• This novel platform offers potential for cross-protection against both Shigella and ETEC infections.
• The stable, non-replicating nature of OMVs enhances vaccine safety and production consistency.